Friday, April 10, 2026

Samchundang Pharm Announces 250 Billion KRW Stake Sale…Expectations Rise for Future Growth

Samchundang Pharm's CEO plans a 2.5 billion KRW share sale for tax purposes, hinting at significant news and future growth in pharma.

APR’s Medicube Becomes First K-Beauty Brand to Join Coachella as Official Sponsor

APR's Medicube brand will sponsor Coachella, showcasing beauty tech and products to enhance global brand awareness.

Ubicare Targets 80%+ Operating Profit Growth in 2026 — Here’s What’s Changing in Its EMR and Platform Play

Ubicare reported a 46% increase in operating profit for 2025, driven by optimized revenue structures and plans for AI solutions in 2026.

Tag: Samchundang Pharma

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Samchundang Pharma CEO Claims FDA Recognition for Obesity Drug as Generic

Samchundang Pharma's CEO announces FDA recognition of oral semaglutide as a generic and withdraws $1.7 billion stock sale plan.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.